Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in moderate COPD
2006-000418-20Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Gefitinib with Placebo (2 arms). Primary endpoints: Cough symptoms and Sputum production symptoms. Started Mar 2006; status: terminated.
02
Drugs
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-000418-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000418-20.